全文获取类型
收费全文 | 4586篇 |
免费 | 354篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 138篇 |
妇产科学 | 50篇 |
基础医学 | 540篇 |
口腔科学 | 29篇 |
临床医学 | 611篇 |
内科学 | 934篇 |
皮肤病学 | 42篇 |
神经病学 | 396篇 |
特种医学 | 159篇 |
外科学 | 981篇 |
综合类 | 72篇 |
一般理论 | 5篇 |
预防医学 | 373篇 |
眼科学 | 94篇 |
药学 | 250篇 |
中国医学 | 4篇 |
肿瘤学 | 244篇 |
出版年
2023年 | 44篇 |
2022年 | 88篇 |
2021年 | 212篇 |
2020年 | 81篇 |
2019年 | 156篇 |
2018年 | 173篇 |
2017年 | 137篇 |
2016年 | 142篇 |
2015年 | 184篇 |
2014年 | 265篇 |
2013年 | 287篇 |
2012年 | 379篇 |
2011年 | 376篇 |
2010年 | 180篇 |
2009年 | 170篇 |
2008年 | 269篇 |
2007年 | 249篇 |
2006年 | 226篇 |
2005年 | 222篇 |
2004年 | 199篇 |
2003年 | 195篇 |
2002年 | 181篇 |
2001年 | 18篇 |
2000年 | 16篇 |
1999年 | 22篇 |
1998年 | 27篇 |
1997年 | 15篇 |
1996年 | 20篇 |
1995年 | 13篇 |
1994年 | 10篇 |
1992年 | 13篇 |
1991年 | 11篇 |
1989年 | 10篇 |
1987年 | 15篇 |
1986年 | 10篇 |
1984年 | 10篇 |
1983年 | 13篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 18篇 |
1979年 | 21篇 |
1978年 | 23篇 |
1977年 | 15篇 |
1976年 | 13篇 |
1975年 | 12篇 |
1973年 | 9篇 |
1972年 | 16篇 |
1971年 | 10篇 |
1964年 | 9篇 |
1940年 | 9篇 |
排序方式: 共有4952条查询结果,搜索用时 15 毫秒
71.
72.
Phlorizin: a review 总被引:4,自引:0,他引:4
The dihydrochalcone phlorizin is a natural product and dietary constituent found in a number of fruit trees. It has been used as a pharmaceutical and tool for physiology research for over 150 years. Phlorizin's principal pharmacological action is to produce renal glycosuria and block intestinal glucose absorption through inhibition of the sodium-glucose symporters located in the proximal renal tubule and mucosa of the small intestine.This review covers the role phlorizin has played in the history of diabetes mellitus and its use as an agent to understand fundamental concepts in renal physiology as well as summarizes the physiology of cellular glucose transport and the pathophysiology of renal glycosuria. It reviews the biology and pathobiology of glucose transporters and discusses the medical botany of phlorizin and the potential effects of plant flavonoids, such as phlorizin, on human metabolism. Lastly, it describes the clinical pharmacology and toxicology of phlorizin, including investigational uses of phlorizin and phlorizin analogs in the treatment of diabetes, obesity, and stress hyperglycemia. 相似文献
73.
Children exposed to environmental tobacco smoke (ETS) in their homes have in- creased cough, respiratory illness, airway obstruction, and hyperreactivity. Since an animal model is needed to understand the mechanism by which this occurs, our study was designed to determine if immature rats develop airway obstruction and increased airway reactivity when exposed to sidestream smoke (SSS, respirable suspended particulate concentration 1.00±0.03 mg/m3, CO concentration 6.48±0.29 ppm). In the first of 3 studies, rats were exposed to filtered air (FA) or SSS for 6 hr/day, 5 days/week from day 2 to week 8 or week 15 of life (n = 6-8 in each group). SSS exposure did not change lung resistance (RJ, dynamic lung compliance (Cldyn), lung weighthody weight ratio (LW/BW), pulmonary artery pressure (PPA), body weight, or airway reactivity to methacholine (all P > 0.2, 2-way ANOVA). Regardless of exposure, lungs from younger rats were relatively heavier and more reactive to methacholine than lungs from older rats (P < 0.05, 2-way ANOVA). In the second study, 15-week-old rats were exposed to FA or SSS for 3 hr or for 4 days (6 hr/day, n = 6 in each group). SSS exposure again had no effect on Cldym RL, LW/BW, Ppa, or airway reactivity to methacholine (all P > 0.2, ANOVA). In the third study, rats were exposed to FA or SSS from day 2 to week 11 of life (n = 7 in each group). SSS exposure reduced airway (P = 0.004) but not pulmonary artery (P = 0.63) reactivity to serotonin. We conclude that (1) SSS exposure to the immature rats did not mimic the effects of ETS seen in children, (2) younger rats had greater muscarinic airway reactivity than older rats, and (3) serotonin may play a role in ETS-induced lung problems.Pediatr Pulmonol. 1993; 16:281–288. © 1993 Wiley-Liss, Inc. 相似文献
74.
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis 总被引:11,自引:0,他引:11
Kovalevsky G Gracia CR Berlin JA Sammel MD Barnhart KT 《Archives of internal medicine》2004,164(5):558-563
BACKGROUND: Recurrent pregnancy loss (RPL) is a significant clinical problem. Recently, thrombophilias have been implicated as a possible cause. Factor V Leiden (FVL) and prothrombin gene (G20210A) mutations are the most common types of hereditary thrombophilias, but are usually undiagnosed because most carriers are asymptomatic. The relationship between FVL, G20210A, and RPL has been investigated with conflicting results. This study analyzed existing data to determine whether an association exists. METHODS: A systematic review of the literature was performed. Only case-control studies that defined RPL as 2 or more pregnancy losses in the first or second trimester and that confirmed mutations by DNA analysis were included. Sixteen studies were selected for the FVL meta-analysis and 7 for the G20210A analysis. Stratified and multivariate logistic regression analyses were performed with the use of aggregate data. Results were confirmed by means of fixed- and random-effects meta-analyses models. RESULTS: The combined odds ratios for the association between RPL and FVL and between RPL and G20210A were 2.0 (95% confidence interval, 1.5-2.7; P<.001) and 2.0 (95% confidence interval, 1.0-4.0; P =.03), respectively. Similar results were produced by the logistic regression and both fixed- and random-effects meta-analysis models. CONCLUSIONS: Carriers of FVL or prothrombin gene mutations have double the risk of experiencing 2 or more miscarriages compared with women without thrombophilias. Hereditary thrombophilias may be an unrecognized cause of RPL. We recommend testing for these mutations in women with RPL. 相似文献
75.
Jesse C. DeSimone Elizabeth M. Davenport Jillian Urban Yin Xi James M. Holcomb Mireille E. Kelley Christopher T. Whitlow Alexander K. Powers Joel D. Stitzel Joseph A. Maldjian 《Human brain mapping》2021,42(8):2529
Repetitive head impact (RHI) exposure in collision sports may contribute to adverse neurological outcomes in former players. In contrast to a concussion, or mild traumatic brain injury, “subconcussive” RHIs represent a more frequent and asymptomatic form of exposure. The neural network‐level signatures characterizing subconcussive RHIs in youth collision‐sport cohorts such as American Football are not known. Here, we used resting‐state functional MRI to examine default mode network (DMN) functional connectivity (FC) following a single football season in youth players (n = 50, ages 8–14) without concussion. Football players demonstrated reduced FC across widespread DMN regions compared with non‐collision sport controls at postseason but not preseason. In a subsample from the original cohort (n = 17), players revealed a negative change in FC between preseason and postseason and a positive and compensatory change in FC during the offseason across the majority of DMN regions. Lastly, significant FC changes, including between preseason and postseason and between in‐ and off‐season, were specific to players at the upper end of the head impact frequency distribution. These findings represent initial evidence of network‐level FC abnormalities following repetitive, non‐concussive RHIs in youth football. Furthermore, the number of subconcussive RHIs proved to be a key factor influencing DMN FC. 相似文献
76.
Wojciech Jurczak Simon Rule Peter Martin Rebecca Auer Brad S. Kahl Agnieszka Giza Bożena Jachimczak Ranjana H. Advani Jorge Romaguera Michael Williams Jacqueline Barrientos Ewa Chmielowska John Radford Stephan Stilgenbauer Jesse McGreivy Fong Clow Darrin M. Beaupre Lori Kunkel Michael L. Wang 《Acta haematologica Polonica》2013,44(3):314-318
Bruton's tyrosine kinase (BTK) is a central mediator of B-cell receptor (BCR) signaling essential for normal B-cell development. Ibrutinib is an oral BTK inhibitor that induces apoptosis and inhibits migration and adhesion of malignant B-cells. Updated results of this international, multicenter, phase 2 study of single agent ibrutinib in relapsed or refractory MCL will be presented.Ibrutinib 560 mg PO QD was administered continuously until disease progression. Tumor response was assessed every 2 cycles (one cycle = 28 days). The study enrolled 115 patients (65 bortezomib-naïve, 50 bortezomib-exposed); 111 patients were treated; 110 were evaluable for response. Baseline characteristics included: median age 68 years, time since diagnosis 42 months, number of prior treatments 3; bulky disease (>10 cm) 13%, prior stem cell transplant 10%, high risk MIPI 49%.Median time on treatment was 9.2 months; 53% of patients remain on therapy. Median PFS was 13.9 months and DOR has not yet been reached. Responses increased with longer treatment: comparing to previous data described at ASH 2011, the CR rate increased from 16% to 39%, and the ORR increased from 69% to 75%. 相似文献
77.
78.
79.
80.
Jiang Wei Wang Xiaoyu Ren Jinchang Li Sen Sun Meijun Wang Zheng Jin Jesse S. 《Cognitive computation》2021,13(5):1287-1296
Cognitive Computation - Different artists have their unique painting styles, which can be hardly recognized by ordinary people without professional knowledge. How to intelligently analyze such... 相似文献